IMU Biosciences

Biotech applying high-resolution immune profiling to transplantation and immuno-oncology; raised over $53M in a Series A in June 2026.

View on the globe

$53MEquity raised in 2025–20262025 — · 2026 $53M · 1 equity round
$53MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 2 Jun 2026 to 2 Jun 2026, $53M equity disclosed. Earlier rounds exist but are not sourced.2 Jun 2026: Series A, $53M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ42026Q2Q3Q42027Equity round2 Jun 2026 · Series A · $53M · led by IQ Capital, Molten VenturesSeries A · $53M
Funding history: 1 round from 2 Jun 2026 to 2 Jun 2026, $53M equity disclosed. Earlier rounds exist but are not sourced.2 Jun 2026: Series A, $53M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourced2026Q2Q3Q42027Equity round2 Jun 2026 · Series A · $53M · led by IQ Capital, Molten Ventures$53M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. IMU Biosciences raised before 2 Jun 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series A
    Amount$53MGBP 40M
    Post-money—
    ✓ Confirmed
    Lead
    IQ Capital, Molten Ventures
    Also
    British Business Bank, Meltwind
    Note
    Company release (carried by BioSpace; original BusinessWire page not reachable): Series A 'over $53 million (£40 million)', co-led by IQ Capital and Molten Ventures, 'supported by The British Business Bank and Meltwind alongside existing investors'. The figure is 'over', so a floor. Seedtable's USD 38.0M is an outlier and not used. Release says about USD 60M raised to date; not written as a round. No valuation disclosed. HQ: the release dateline is London; no address on the company site (last-resort rule, flagged).
    Sources
  2. Earlier rounds not yet sourced

Investors 4

  • IQ Capital1
  • Molten Ventures1
  • British Business Bank
  • Meltwind

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the London hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. IMU Biosciences and its logo are trademarks of their owners, used here for identification only.